Search

Luxembourg's National Recovery and Resilience Plan (NRRP) was initially to be financed by the Recovery and Resilience Facility (RRF) with a total of €93.4 million in grants. This allocation accounted for around 51 % of the total estimated value of the Luxembourgish NRRP (€183.1 million). A further 46 % of the costs are to be covered by the national budget, and 3 % from other EU co-financing. Under the RRF Regulation, Member States can request RRF loans until 31 August 2023; Luxembourg has not done ...

During the July plenary session, the European Parliament is expected to discuss the final report of its Special Committee on the COVID-19 pandemic, and vote on a series of recommendations to improve EU preparedness for future health emergencies.

Midway of the 2030 Agenda for Sustainable Development, the High-Level Political Forum 2023 marks a pivotal point in the achievement of the Sustainable Development Goals (SDGs). The impact of the multiple crises of the past years, as well as the interlinkages and synergies of the SDGs present both challenges and opportunities for a systemic approach towards our common objectives. For the global community not to lose the progress in this global decade of action, there is a need for the EU to take the ...

In line with the EU-India Strategic Partnership of 2004 and the EU approach to global health, the EU and India have long-standing cooperation on health. The focus is on health research and innovation, public health and health security, as well as regulatory convergence. Often called the 'world's pharmacy', India significantly shapes global health outcomes due to its health diplomacy and its large share of the global population. While interests converge in numerous health-related areas, intellectual ...

EU support for the implementation of Slovenia's National Recovery and Resilience Plan (NRRP) amounts to €2 482.3 million, and includes €1 776.9 million in grants and €705.4 million in loans. This amount should be committed by the end of 2023, and paid out to Slovenia by the end of 2026. While the overall allocation represents only 0.3 % of the total Recovery and Resilience Facility (RRF), it stood at 5.1 % of the country's gross domestic product (GDP) in 2019 (the RRF being 5.2 % of EU-27 GDP in ...

Over the last 3 years, the European Union has faced major challenges to its economy and societies, including the coronavirus pandemic, Russia's war on Ukraine and the increasingly urgent need for a green economic transition. The EU's response to these exceptional circumstances have included changes to its fiscal, monetary and investment policies, notably through the adaptation of State aid to allow Member States to support their economies by means of more direct intervention. Under competition law ...

On 6 July 2021, the Council approved Slovakia's National Recovery and Resilience Plan (NRRP, Plán obnovy) and allocated €6 328.6 million in grants for its implementation. The allocation covers almost entirely the total cost of the plan, which stands at €6 575 million. In June 2022, Slovakia's grant allocation was revised downwards to €6 007.3 million ( 5.1 %). However, thanks to the February 2023 agreement enabling Member States to add REPowerEU chapters to their plans, Slovakia's envelope will be ...

Wishing to highlight and mitigate the impact of the pandemic on young people, the European Commission President, Ursula von der Leyen, used her 2021 State of the Union address to name 2022 the European Year of Youth (EYY22). Following 12 months of varied youth-related activities, the thematic year concluded with a conference in December 2022. The European Parliament is committed to securing a lasting legacy for EYY22. In that context, Members will ask questions of the Commission on this topic during ...

This study provides a mapping of funds contributed by different actors for the R&D and the expansion of the production capacity of COVID-19 vaccines, with a focus on those authorised in the EU. Nine vaccines are examined. It is found that governments, mainly the US (with some not-for-profit entities) decisively supported corporate investments, either for R&D, manufacturing, or both, by nearly EUR 9 billion, i.e. on average EUR one billion of grants per vaccine, with, however, vast variance across ...

These proceedings summarise the presentations and discussions during the workshop on ‘COVID-19: EU Preparedness and Response’, held on 8 March 2023. The five presentations touched, inter alia, upon the impact of COVID-19 at EU level, and how the EU has been prepared, how it responded to that crisis, and the lessons learned following the pandemic. These workshop proceedings were provided by the Policy Department for Economic, Scientific and Quality of Life Policies for the Special Committee on COVID ...